Forster, M., Chaikuad, A., Dimitrov, T., During E, Holstein J, Berger BT, ... Laufer SA. (2018). Development, Optimization and Structure-Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold. Journal of Medicinal Chemistry, 61(12), 5350-5366.

Date
PubMed ID
29852068
Author(s)
Forster M, Chaikuad A, Dimitrov T, During E, Holstein J, Berger BT, Gehringer M, Ghoreschi K, Muller S, Knapp S, Laufer SA.
Year
2018